481 related articles for article (PubMed ID: 17404492)
21. [First choice drug for treatment of osteoporosis and the strategic points for choice of drugs].
Soen S
Nihon Rinsho; 2007 Nov; 65 Suppl 9():325-8. PubMed ID: 18159713
[No Abstract] [Full Text] [Related]
22. Osteoporosis disease management for fragility fracture patients: new understandings based on three years' experience with an osteoporosis care service.
Harrington JT; Lease J
Arthritis Rheum; 2007 Dec; 57(8):1502-6. PubMed ID: 18050169
[TBL] [Abstract][Full Text] [Related]
23. [Calcitonin].
Nakano T
Clin Calcium; 2008 Oct; 18(10):1460-8. PubMed ID: 18830043
[TBL] [Abstract][Full Text] [Related]
24. Tolerance and effectiveness on pain control of Pamidronate® intravenous infusions in children with neuromuscular disorders.
Wagner S; Poirot I; Vuillerot C; Berard C
Ann Phys Rehabil Med; 2011 Sep; 54(6):348-58. PubMed ID: 21840280
[TBL] [Abstract][Full Text] [Related]
25. Osteoporosis and vertebral compression fractures-continued missed opportunities.
Freedman BA; Potter BK; Nesti LJ; Giuliani JR; Hampton C; Kuklo TR
Spine J; 2008; 8(5):756-62. PubMed ID: 18343730
[TBL] [Abstract][Full Text] [Related]
26. [Goals of treatment for osteoporosis].
Nakamura T
Clin Calcium; 2008 Oct; 18(10):1389-95. PubMed ID: 18830034
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of osteoporosis with parathyroid hormone].
Syversen U; Halse JI
Tidsskr Nor Laegeforen; 2008 Jan; 128(1):39-41. PubMed ID: 18183056
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates.
Earnshaw SR; Graham CN; Ettinger B; Amonkar MM; Lynch NO; Middelhoven H
Curr Med Res Opin; 2007 Oct; 23(10):2517-29. PubMed ID: 17825128
[TBL] [Abstract][Full Text] [Related]
29. [Prophylaxis of glucocorticoid-induced osteoporosis].
Tanaka Y
Clin Calcium; 2006 Nov; 16(11):1858-65. PubMed ID: 17079853
[TBL] [Abstract][Full Text] [Related]
30. [The efficacy of strontium ranelate (Osseor) on fractures in osteoporosis].
Novak S
Reumatizam; 2008; 55(2):75-7. PubMed ID: 19024282
[TBL] [Abstract][Full Text] [Related]
31. What is new in the treatment of steroid-induced osteoporosis?
Liu RH; Werth VP
Semin Cutan Med Surg; 2007 Dec; 26(4):203-9. PubMed ID: 18395668
[TBL] [Abstract][Full Text] [Related]
32. The osteoporosis care gap in Canada.
Papaioannou A; Giangregorio L; Kvern B; Boulos P; Ioannidis G; Adachi JD
BMC Musculoskelet Disord; 2004 Apr; 5():11. PubMed ID: 15068488
[TBL] [Abstract][Full Text] [Related]
33. [Improvement of QOL in osteoporotic patients by calcitonin treatment].
Tanaka K; Yoshizawa M; Yoh K
Clin Calcium; 2005 Mar; 15(3):174-8. PubMed ID: 15741699
[TBL] [Abstract][Full Text] [Related]
34. [Glucocorticoid induced osteoporosis in childhood: prophylaxis and treatment].
Tanaka H
Clin Calcium; 2009 Apr; 19(4):569-73. PubMed ID: 19329838
[TBL] [Abstract][Full Text] [Related]
35. [Bisphosphonate and mechanical stress on bone].
Endo I; Matsumoto T
Clin Calcium; 2008 Sep; 18(9):1321-6. PubMed ID: 18758038
[TBL] [Abstract][Full Text] [Related]
36. [Evidence for efficacy of active vitamin D3 as an anti-osteoporotic drug].
Inoue D
Clin Calcium; 2008 Oct; 18(10):1469-75. PubMed ID: 18830044
[TBL] [Abstract][Full Text] [Related]
37. [Up-to-date treatments for osteoporosis].
Bors K
Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157
[TBL] [Abstract][Full Text] [Related]
38. [Pharmaceutical treatment for patients with hip fracture].
Hagino H
Clin Calcium; 2010 Sep; 20(9):1394-400. PubMed ID: 20808048
[TBL] [Abstract][Full Text] [Related]
39. [Therapy of osteoporosis].
Fassbender WJ
MMW Fortschr Med; 2008 Jul; 150(28-31):44-7. PubMed ID: 19009706
[No Abstract] [Full Text] [Related]
40. [Bisphosphonate therapy for children and adolescents with primary and secondary osteoporotic diseases].
Semler O; Land C; Schönau E
Orthopade; 2007 Feb; 36(2):146-51. PubMed ID: 17252257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
